EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Challenges and Opportunities in State‐of‐the‐Art Proteomics Analysis for Biomarker Development From Plasma Extracellular Vesicles

Panshak P Dakup iD, Ivo Diaz Ludovico iD, Youngki You iD, Chaitra Rao iD, Javier Flores iD, Lisa M Bramer iD, Marian Rewers iD, Bobbie-Jo M Webb-Robertson iD, Thomas O Metz iD, Raghavendra G Mirmira iD, Emily K Sims iD, Ernesto S Nakayasu iD

PROTEOMICS · 2026-02 · 26 (2-3) · 9-20

DOI: 10.1002/pmic.70036 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PROTEOMICS, online erschienen am 16.09.2025. Verfasst von Panshak P Dakup und 11 weiteren Autor:innen. Beteiligte Einrichtung: Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington, USA. Hauptthemen laut MEDLINE: Extracellular Vesicles, Proteomics, Biomarkers, Proteome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Breakthrough T1D fellowship, Diabetes Research Connection.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) are membrane‐bound particles secreted by cells, playing crucial roles in intercellular communication. The composition of EVs can undergo changes in response to stress and disease conditions, making them excellent biomarker candidates. However, extracting protein information from EVs can be challenging due to their low abundance in complex biofluids and copurification with contaminant proteins and particles. Techniques to enrich EVs have their strengths and limitations, without one being able to purify EVs to complete homogeneity. This can lead to compromised recovery rates and increased complexity, making data interpretation difficult. In this viewpoint article, we explore the concept that better characterization of EV composition, followed by quantification of EV proteins in complex samples, might be a more viable route for biomarker development. Mass spectrometers can provide reproducible deep coverage of the EV proteome, despite sample impurities. This paradigm shift presents opportunities to integrate advanced bioinformatics tools to refine the EV proteome landscape, identify novel biomarkers, and streamline validation processes in biomarker development. By focusing on leveraging technology rather than achieving absolute purity, this approach can transform current practices and open opportunities for robust biomarker discovery. Herein, we highlight not only such opportunities but also challenges to implement this concept. Summary Extracellular vesicles (EVs) have enormous potential as biomarkers of diseases, as they can carry signatures of the cells they are derived from and the pathogenesis process. Biofluids, such as blood plasma, are highly complex and contain many components with physicochemical properties similar to those of EVs, making it challenging to obtain pure EV fractions. Challenges in obtaining pure preparations represent a main hurdle for studying EVs, and their components are potential biomarkers. This article explores the concept of studying EV proteins within complex samples, discussing opportunities and needs to move this field forward.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesProteomicsBiomarkersProteomeHumansMass Spectrometry

Substanzen

BiomarkersProteome

Autor:innen und Institutionen

  • Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington, USA.
  • Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Barbara Davis Center For Diabetes, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Department of Medicine and the Kovler Diabetes Center, The University of Chicago, Chicago, Illinois, USA.

ORCID-Profile: Panshak P Dakup, Ivo Diaz Ludovico, Youngki You, Chaitra Rao, Javier Flores, Lisa M Bramer, Marian Rewers, Bobbie-Jo M Webb-Robertson, Thomas O Metz, Raghavendra G Mirmira, Emily K Sims, Ernesto S Nakayasu

Förderung

  • NIDDK NIH HHS
  • Breakthrough T1D fellowship
  • Diabetes Research Connection
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Dakup, P. P., Ludovico, I. D., You, Y., Rao, C., Flores, J., Bramer, L. M., Rewers, M., Webb-Robertson, B. M., Metz, T. O., Mirmira, R. G., Sims, E. K., & Nakayasu, E. S. (2026). Challenges and Opportunities in State‐of‐the‐Art Proteomics Analysis for Biomarker Development From Plasma Extracellular Vesicles. PROTEOMICS, 26(2-3), 9-20. https://doi.org/10.1002/pmic.70036

Vancouver

Dakup PP, Ludovico ID, You Y, Rao C, Flores J, Bramer LM, et al. Challenges and Opportunities in State‐of‐the‐Art Proteomics Analysis for Biomarker Development From Plasma Extracellular Vesicles. PROTEOMICS. 2026;26(2-3):9-20. doi:10.1002/pmic.70036

BibTeX
@article{Dakup2026,
  author = {Dakup, Panshak P and Ludovico, Ivo Diaz and You, Youngki and Rao, Chaitra and Flores, Javier and Bramer, Lisa M and Rewers, Marian and Webb-Robertson, Bobbie-Jo M and Metz, Thomas O and Mirmira, Raghavendra G and Sims, Emily K and Nakayasu, Ernesto S},
  title = {Challenges and Opportunities in State‐of‐the‐Art Proteomics Analysis for Biomarker Development From Plasma Extracellular Vesicles},
  journal = {PROTEOMICS},
  year = {2026},
  volume = {26},
  number = {2-3},
  pages = {9--20},
  doi = {10.1002/pmic.70036}
}
Kostenlos starten →